2002
DOI: 10.1016/s0303-8467(02)00040-9
|View full text |Cite
|
Sign up to set email alerts
|

The natural history of untreated multiple sclerosis in Iceland. A total population-based 50 year prospective study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
53
1

Year Published

2005
2005
2012
2012

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(58 citation statements)
references
References 6 publications
4
53
1
Order By: Relevance
“…8 Older studies from Iceland found the proportion of women to be 58% (1956)(1957)(1958)(1959)(1960)(1961)(1962)(1963)(1964)(1965) 4 and 69% (1986)(1987)(1988)(1989)(1990). 3 This apparent increase in the proportion of women with MS in Iceland is comparable with several studies that have reported an increasing proportion of women 2 being diagnosed with MS.…”
Section: Discussionsupporting
confidence: 86%
See 1 more Smart Citation
“…8 Older studies from Iceland found the proportion of women to be 58% (1956)(1957)(1958)(1959)(1960)(1961)(1962)(1963)(1964)(1965) 4 and 69% (1986)(1987)(1988)(1989)(1990). 3 This apparent increase in the proportion of women with MS in Iceland is comparable with several studies that have reported an increasing proportion of women 2 being diagnosed with MS.…”
Section: Discussionsupporting
confidence: 86%
“…Two studies from Iceland have reported the incidence of MS to be 4.98-5.28 per 100,000 (1981)(1982)(1983)(1984)(1985)(1986)(1987)(1988)(1989)(1990) 3 and 1.94 per 100,000 (1956)(1957)(1958)(1959)(1960)(1961)(1962)(1963)(1964)(1965). 4 We determined the incidence of clinically definite MS and the results of the principal diagnostic studies used in the diagnosis of MS.…”
Section: Introductionmentioning
confidence: 99%
“…Recent studies suggest that MS may be a rather more benign disease than has previously recognised (27,28), even according to a 50-year prospective study in untreated MS subjects (29). Subjects can fare relatively well without these new disease-modifying therapies and available medications have, at best, moderate shortterm efficacy (28).…”
Section: Discussionmentioning
confidence: 99%
“…Given the emphasis on early treatment of MS, it is likely that more patients with milder disease will begin diseasemodifying therapies. It is possible, even likely, that some of these mild cases might have a good prognosis even without treatment 27,28 ; thus patients may be subjected to unnecessary adverse effects and costs of therapy. 29 Unfortunately, the capacity to distinguish which patients will have a mild vs severe disease course is poor.…”
mentioning
confidence: 99%